TSWM
BIIB icon

Triangle Securities Wealth Management’s Biogen BIIB Stock Holding History

Triangle Securities Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,380
Closed -$326K – 203
2025
Q1 		$326K Sell
2,380
-20
-0.8% -$2.86K 0.08% 178
2024
Q4 		$367K Hold
2,400
– – 0.09% 170
2024
Q3 		$465K Hold
2,400
– – 0.12% 157
2024
Q2 		$556K Hold
2,400
– – 0.16% 141
2024
Q1 		$518K Hold
2,400
– – 0.15% 140
2023
Q4 		$621K Hold
2,400
– – 0.19% 126
2023
Q3 		$617K Sell
2,400
-100
-4% -$26.7K 0.22% 116
2023
Q2 		$712K Hold
2,500
– – 0.25% 114
2023
Q1 		$695K Sell
2,500
-81
-3% -$22.4K 0.25% 112
2022
Q4 		$715K Sell
2,581
-372
-13% -$105K 0.26% 111
2022
Q3 		$788K Sell
2,953
-78
-3% -$16.6K 0.32% 90
2022
Q2 		$618K Sell
3,031
-159
-5% -$32.5K 0.24% 111
2022
Q1 		$672K Sell
3,190
-57
-2% -$12.4K 0.23% 119
2021
Q4 		$779K Sell
3,247
-200
-6% -$51.4K 0.24% 109
2021
Q3 		$975K Sell
3,447
-38
-1% -$12.5K 0.33% 92
2021
Q2 		$1.21M Sell
3,485
-499
-13% -$151K 0.41% 77
2021
Q1 		$1.11M Sell
3,984
-167
-4% -$45K 0.4% 78
2020
Q4 		$1.02M Sell
4,151
-342
-8% -$88.2K 0.4% 80
2020
Q3 		$1.27M Sell
4,493
-110
-2% -$30.7K 0.58% 60
2020
Q2 		$1.23M Sell
4,603
-486
-10% -$146K 0.59% 60
2020
Q1 		$1.61M Sell
5,089
-588
-10% -$178K 0.93% 35
2019
Q4 		$1.69M Sell
5,677
-634
-10% -$176K 0.73% 45
2019
Q3 		$1.47M Sell
6,311
-380
-6% -$88.5K 0.72% 46
2019
Q2 		$1.54M Sell
6,691
-122
-2% -$28.2K 0.78% 44
2019
Q1 		$1.61M Buy
6,813
+60
+0.9% +$18.9K 0.84% 42
2018
Q4 		$2.03M Buy
6,753
+100
+2% +$31.9K 1.2% 26
2018
Q3 		$2.35M Sell
6,653
-180
-3% -$62K 1.25% 23
2018
Q2 		$1.98M Sell
6,833
-70
-1% -$19.7K 1.11% 31
2018
Q1 		$1.89M Buy
6,903
+312
+5% +$96.8K 1.09% 31
2017
Q4 		$2.1M Sell
6,591
-166
-2% -$53.3K 1.2% 26
2017
Q3 		$2.12M Sell
6,757
-158
-2% -$46.8K 1.26% 28
2017
Q2 		$1.88M Sell
6,915
-25
-0.4% -$6.61K 1.24% 30
2017
Q1 		$1.9M Sell
6,940
-95
-1% -$26.9K 1.21% 31
2016
Q4 		$2M Sell
7,035
-45
-0.6% -$13.3K 1.33% 23
2016
Q3 		$2.22M Sell
7,080
-590
-8% -$175K 1.53% 18
2016
Q2 		$1.85M Sell
7,670
-1,195
-13% -$315K 1.38% 26
2016
Q1 		$2.31M Sell
8,865
-50
-0.6% -$13.2K 1.51% 19
2015
Q4 		$2.73M Buy
8,915
+116
+1% +$33.3K 1.83% 13
2015
Q3 		$2.57M Buy
8,799
+101
+1% +$33.4K 1.94% 12
2015
Q2 		$3.51M Sell
8,698
-22
-0.3% -$8.83K 2.48% 5
2015
Q1 		$3.68M Sell
8,720
-1,101
-11% -$434K 2.55% 6
2014
Q4 		$3.33M Buy
9,821
+553
+6% +$179K 2.37% 7
2014
Q3 		$3.07M Sell
9,268
-394
-4% -$130K 2.36% 7
2014
Q2 		$3.05M Sell
9,662
-263
-3% -$79.2K 2.33% 7
2014
Q1 		$1.91M Buy
9,925
+364
+4% +$116K 1.72% 16
2013
Q4 		$2.67M Sell
9,561
-73
-0.8% -$18.9K 2.17% 9
2013
Q3 		$2.32M Sell
9,634
-1,166
-11% -$261K 2.02% 12
2013
Q2 		$2.32M Buy
+10,800
New +$2.31M 1.72% 12

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Triangle Securities Wealth Management's BIIB Position: Q2 2025 in Review

Triangle Securities Wealth Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 2,380 shares — an estimated $326K sold.

Triangle Securities Wealth Management first reported a position in BIIB in Q2 2013 and held it in 48 quarters. The position peaked at $3.68M in Q1 2015. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Triangle Securities Wealth Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Triangle Securities Wealth Management sold 2,380 Biogen shares in Q2 2025, an estimated $326K.
  • Triangle Securities Wealth Management first reported a position in Biogen in Q2 2013 and held it in 48 quarters.
  • Triangle Securities Wealth Management's Biogen position peaked at $3.68M in Q1 2015.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Triangle Securities Wealth Management's 13F filing for Q2 2025, filed 10 Jul 2025.